Source: CNET

Valencell: CES 2023 Unveils Calibration-Free, Fingertip Blood Pressure Monitor - CNET

Valencell's over-the-counter blood pressure monitor is pending FDA approval following its CES 2023 announcement.

Read full article »
Valencell's Competitors | Valencell's News | Valencell's Financials
Stay up-to-date with the latest news on Valencell
Est. Annual Revenue
$25-100M
Est. Employees
100-250
Kent Novak's photo - CEO of Valencell

CEO

Kent Novak

CEO Approval Rating

85/100

Read more
Stay up-to-date with the latest news on Valencell